Pricing Log in Create free account
Saturday 17 October 2026 Export RMD’s income statement to Excel — free account

ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

238.97 3.26 −1.35%
Market cap
$34.1B
P/E
22.8×
Fwd P/E
16.6×
Dividend yield
1.03%
F-score
6/9
Altman Z
10.00
Beneish M
−2.59
Dividend safety
96/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

ResMed Inc. (RMD) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, ResMed Inc. (RMD) trades at a price to free cash flow of 21.4×. Over the past ten years it has ranged from 12.9× (January 2016) to 182× (August 2022); the current reading is higher than 25% of that period. That is below the Medical Instruments & Supplies industry median of 25.2× and above the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2026 17.4× (24.05%)
FY2025 22.9× 7.31%
FY2024 21.4× (62.74%)
FY2023 57.3× (63.47%)
FY2022 157× 171.57%
FY2021 57.8× 45.20%
FY2020 39.8× (14.23%)
FY2019 46.4× 35.78%
FY2018 34.2× 6.35%
FY2017 32.1× 73.97%

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 17.4× (7.33%)
Mar 2026 18.8× (4.97%)
Dec 2025 19.8× (13.20%)
Sep 2025 22.8× (0.65%)
42 more quarters

Against its own ten years

Low 12.9× High 182×
Ten-year median 32.2×
Current reading's percentile 25

Price to free cash flow against peers

Company Price to free cash flow
SOLV Solventum Corporation compare n/m
MDLN Medline Inc. compare 13.4×
BAX Baxter International Inc. compare 16.1×
BDX Becton, Dickinson and Company compare 16.5×
COO The Cooper Companies, Inc. compare 16.5×
ALC Alcon compare 20.2×
RMD ResMed Inc. 21.4×
WST West Pharmaceutical Services, Inc. compare 62.6×
RGEN Repligen Corporation compare 162×
Medical Instruments & Supplies industry median 25.2×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on RMD